Notizie AIOM – anno XV
Web-app
Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul melanoma è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, per ...Leggi tutto
XXXV CONFERENZA NAZIONALE DI CITOMETRIA Aggiornamenti e Innovazioni della Citometria nelle Applicazioni Cliniche e di Ricerca
Paestum (SA), 3 - 6 ottobre 2017 I Soci AIOM potranno usufruire della stessa quota d'iscrizione ridotta per i Soci GIC Bando per il Premio di Studio “Marcello Spanò” GIC 2017, 31^ edizione, dal titolo: “La Citometria nelle tesi sperimentali ed in ...Leggi tutto
Premi per incentivare la ricerca di specialisti in Oncologia e Geriatria
Il Gruppo Italiano di Oncologia Geriatrica - GIOGer, istituisce tre premi di 1.000 euro netti ciascuno, che saranno conferiti in occasione del prossimo Congresso nazionale di Oncologia Geriatrica che si terrà a Lecce il 15 e 16 Settembre 2017. Scadenza domande: 30 ...Leggi tutto
Tracking the Evolution of Non–Small-Cell Lung Cancer
Among patients with non–small-cell lung cancer (NSCLC), data on intratumor heterogeneity and cancer genome evolution have been limited to small retrospec- tive cohorts. We wanted to prospectively investigate intratumor heterogeneity in relation to clinical outcome ...Leggi tutto
Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study
To determine the demographic, clinical, decision-making, and quality-of-life factors that are associated with treatment decision regret among long-term survivors of localized prostate cancer. We evaluated men who were age ≤ 75 years when diagnosed with localized prostate ...Leggi tutto
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction
Men with metastatic prostate cancer who have a poor response to initial androgen-deprivation therapy (ADT), as reflected by a prostate-specific antigen (PSA) level higher than 4.0 ng/mL after 7 months of ADT, have a poor prognosis, based on historical controls. To determine ...Leggi tutto
Changes in HER2 Breast Cancer Testing According to 2007 and 2013 ASCO/CAP Guidelines
May 15, 2017 - Hanna et al have reported that the 2013 update to the 2007 ASCO/College of American Pathologists (CAP) recommendations for HER2 testing in breast cancer did not result in changes in the overall HER2-positivity rate but was associated with a higher rate of ...Leggi tutto
New Canadian Guideline Provides Advice to Physicians to Avoid Overprescribing of Opioids
May 16, 2017 - Opioid overdoses are claiming the lives of thousands of Canadians. The impact of the opioid crisis continues to be devastating to individuals, families, and communities. Inappropriate prescribing of opioids has led to long-term dependence on this class of ...Leggi tutto